Old Web
English
Sign In
Acemap
>
Paper
>
Dose-adjusted EPOCH-Rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma.
Dose-adjusted EPOCH-Rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma.
2021
Fabian Knörr
Martin Zimmermann
Andishe Attarbaschi
Edita Kabickova
Britta Maecker-Kolhoff
Stephanie Ruf
Ingrid Kühnle
Martin Ebinger
Anne-Kathrin Garthe
Ingrid Simonitsch-Klupp
Ilske Oschlies
Wolfram Klapper
Birgit Burkhardt
Wilhelm Woessmann
Keywords:
Rituximab
epoch
Oncology
Primary Mediastinal Large B-Cell Lymphoma
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]